Today, Merck & Co. is an established top global player on the pharmaceutical market, generating over 42 billion U.S. dollars of revenue. The roots of Merck & Co., Inc. can be traced back to the 17th century: The company began as a purchased drug store in Darmstadt, Germany, in 1668 under Jacob Friedrich Merck. In 1891, a subsidiary became active in the United States under the name Merck & Co. Since 1917, when it was confiscated by the U.S. during the World War, Merck & Co. is an independent U.S. American company.
The company’s products range from vaccines and oncology to animal health. A large portion of Merck & Co.’s revenues are generated from oncology, diabetes and vaccine products. As a company Merck & Co. has one of the highest numbers of approved drugs, spending significant amounts on research and development. In recent years, two of its most important products are targeting chronic diseases that plague society. Januvia (sitagliptin) is one of the best-selling diabetes drugs globally and is popular as it does not cause weight gain. The drug generated some 3.5 billion U.S. dollars in revenue in 2019.
Merck & Co. is an international company, generating more than half of its revenues outside the United States. As one of the largest pharmaceutical companies in the world, Merck & Co. had some 71,000 employees in 2019, spread over 100 countries. The company had total assets accounting for 84 billion U.S. dollars in the same year.
This text provides general information. Statista assumes no
liability for the information given being complete or correct.
Due to varying update cycles, statistics can display more up-to-date
data than referenced in the text.
In the following 5 chapters, you will quickly find the 23 most important statistics relating to "Merck & Co.".